Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

908 Devices (MASS) Change in Accured Expenses (2020 - 2025)

Historic Change in Accured Expenses for 908 Devices (MASS) over the last 6 years, with Q3 2025 value amounting to $218000.0.

  • 908 Devices' Change in Accured Expenses fell 8856.84% to $218000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.6 million, marking a year-over-year decrease of 38116.63%. This contributed to the annual value of $2.3 million for FY2024, which is 1406.79% up from last year.
  • 908 Devices' Change in Accured Expenses amounted to $218000.0 in Q3 2025, which was down 8856.84% from -$41000.0 recorded in Q2 2025.
  • In the past 5 years, 908 Devices' Change in Accured Expenses ranged from a high of $2.1 million in Q3 2023 and a low of -$5.6 million during Q1 2025
  • Moreover, its 5-year median value for Change in Accured Expenses was $583000.0 (2022), whereas its average is $112315.8.
  • The largest annual percentage gain for 908 Devices' Change in Accured Expenses in the last 5 years was 15664.94% (2024), contrasted with its biggest fall of 42241.89% (2024).
  • Quarter analysis of 5 years shows 908 Devices' Change in Accured Expenses stood at $1.3 million in 2021, then plummeted by 51.99% to $627000.0 in 2022, then increased by 28.39% to $805000.0 in 2023, then surged by 130.43% to $1.9 million in 2024, then tumbled by 88.25% to $218000.0 in 2025.
  • Its Change in Accured Expenses stands at $218000.0 for Q3 2025, versus -$41000.0 for Q2 2025 and -$5.6 million for Q1 2025.